Evidence map›Paper›PMID 38041430›Full record

ArticleJournal of primary care & community health

Identifying Discrepancies in Gestational Diabetes Mellitus Postpartum Follow-Up During Care Transitions.

Brittany Strelow, Justine Herndon, Alex Ferrier, Madysen McCormick, AnneMarie McMahon, Emily Schlechtinger, Deborah Shefa, Mark Takagi, Rozalina McCoy, Rachel Olson and 1 more

Abstract read
In one paragraph

Article in Journal of primary care & community health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Brittany StrelowMayo Clinic, Rochester, MN, USA.ORCID 0000-0003-4858-3279
Justine HerndonMayo Clinic, Rochester, MN, USA.ORCID 0000-0001-5665-0617
Alex FerrierMayo Clinic Physician Assistant Program, Rochester, MN, USA.
Madysen McCormickMayo Clinic Physician Assistant Program, Rochester, MN, USA.
AnneMarie McMahonMayo Clinic Physician Assistant Program, Rochester, MN, USA.
Emily SchlechtingerMayo Clinic Physician Assistant Program, Rochester, MN, USA.
Deborah ShefaMayo Clinic Physician Assistant Program, Rochester, MN, USA.
Mark TakagiMayo Clinic Knowledge and Evaluation Research Unit, Rochester, MN, USA.
Rozalina McCoyMayo Clinic, Rochester, MN, USA.
Rachel OlsonUniversity of Minnesota, Rochester, MN, USA.
Danielle O'LaughlinMayo Clinic, Rochester, MN, USA.ORCID 0000-0002-2579-2740

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGestational diabetes mellitus (GDM) is a common complication of pregnancy that carries lasting risks. For women who have a history of GDM, the risk of developing type 2 diabetes mellitus (T2DM) increases by 50 to 60%. To monitor and prevent the development of T2DM, guidelines suggest screening those with a history of GDM at 6-weeks and 3-years post-delivery. For patients with abnormal lab results at the 6-week mark, it is advised to complete lab work sooner, at the 1-year mark. Data suggests that these guidelines are not being followed globally, and most do not receive adequate screening for T2DM.

methodsA retroactive chart review of 203 women between 18 and 55 years old with a past medical history significant for GDM was conducted to determine if patients with GDM completed screening for T2DM at 6-week, 1-year, and 3-year timestamps post-delivery. Patient demographics (age, race, ethnicity, language), clinical characteristics (body mass index), provider gender, and whether prediabetes or T2DM developed were recorded. Patients who did not complete the required follow-up received educational materials via the online portal system, and hemoglobin A1c (HbA1c) screening tests were ordered.

resultsNinety days post-intervention, 38 patients (50%) completed the HbA1c screening test, which exceeded our goal of a 5% improvement. Age and BMI 1-year postpartum were found to be significant factors in whether a patient completed HbA1c screening, with 16/18 (89%) completing screening with a healthy BMI 1-year postpartum (18.5 ≤ BMI < 25.0) but only 11/41 (27%) completing screening for patients under 40 years with an unhealthy BMI 1-year postpartum. Of the 38 patients who completed HbA1c screening, 9 (23.7%) had abnormal screening results.

conclusionFollow-up surveillance for T2DM among women with a history of GDM is poor. Electronic health records can be used to identify and rectify gaps in care. Dissemination of standardized educational materials and electronic order entry for patients improved screening between the handoff from obstetrics to primary care.

Indexed as

Diabetes, GestationalDiabetes Mellitus, Type 2AdolescentAdultBlood GlucoseFemaleFollow-Up StudiesGlucose Tolerance TestGlycated HemoglobinHumansMiddle AgedPatient TransferPostpartum PeriodPregnancyYoung AdultBlood GlucoseGlycated Hemoglobindiabetes mellitusgestational diabetesgynecologyhealth promotionobstetricsprimary carequality improvement

Identifiers

PMID38041430
PMCPMC10693797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.